The aggregation of α-synuclein (α-syn) has been implicated in the pathogenesis of many neurodegenerative disorders, including Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). Postmortem analyses of α-syn pathology, especially that of PD, have suggested that aggregates progressively spread from a few discrete locations to wider brain regions. The neuron-to-neuron propagation of α-syn has been suggested to be the underlying mechanism by which aggregates spread throughout the brain. Many cellular and animal models has been created to study cell-to-cell propagation. Recently, it has been shown that a single injection of preformed fibrils (PFFs) made of recombinant α-syn proteins into various tissues and organs of many different animal species results in widespread α-syn pathology in the central nervous system (CNS). These PFF models have been extensively used to study the mechanism by which aggregates spread throughout the brain. Here, we review what we have learned from PFF models, describe the nature of PFFs and the neuropathological features, neurophysiological characteristics, and behavioral outcomes of the models.
Citations
Citations to this article as recorded by
Glial senescence enhances α-synuclein pathology owing to its insufficient clearance caused by autophagy dysfunction Bin Hong, Yosuke Ohtake, Takahide Itokazu, Toshihide Yamashita Cell Death Discovery.2024;[Epub] CrossRef
A Surface Imprinted Polymer EIS Sensor for Detecting Alpha-Synuclein, a Parkinson’s Disease Biomarker Roslyn Simone Massey, Rishabh Ramesh Appadurai, Ravi Prakash Micromachines.2024; 15(2): 273. CrossRef
Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration Nasir Uddin Mahbub, Md Minarul Islam, Seong-Tshool Hong, Hea-Jong Chung Frontiers in Cellular and Infection Microbiology.2024;[Epub] CrossRef
Neuropathogenesis-on-chips for neurodegenerative diseases Sarnai Amartumur, Huong Nguyen, Thuy Huynh, Testaverde S. Kim, Ran-Sook Woo, Eungseok Oh, Kyeong Kyu Kim, Luke P. Lee, Chaejeong Heo Nature Communications.2024;[Epub] CrossRef
Systemic inflammation activates coagulation and immune cell infiltration pathways in brains with propagating α-synuclein fibril aggregates Anne-Line Strange Laursen, Mikkel Vestergaard Olesen, Jonas Folke, Tomasz Brudek, Luisa Harriet Knecht, Florence Sotty, Kate Lykke Lambertsen, Karina Fog, Louise Torp Dalgaard, Susana Aznar Molecular and Cellular Neuroscience.2024; 129: 103931. CrossRef
Comparison of Aptamer and Antibody Bioreceptors in the OEGFET Biosensor Platform for Detecting α-Synuclein, a Parkinson's Biomarker Roslyn S. Massey, Srishti Johri, Dennis Chan, Matthew R. Holahan, Ravi Prakash IEEE Sensors Letters.2024; 8(7): 1. CrossRef
Cognitive dysfunction in animal models of human lewy-body dementia Caroline Haikal, Graham M. Winston, Michael G. Kaplitt Frontiers in Aging Neuroscience.2024;[Epub] CrossRef
Non-invasive Monitoring of α-Synuclein in Saliva for Parkinson’s Disease Using Organic Electrolyte-Gated FET Aptasensor Roslyn S. Massey, Erin M. McConnell, Dennis Chan, Matthew R. Holahan, Maria C. DeRosa, Ravi Prakash ACS Sensors.2023; 8(8): 3116. CrossRef
CSF-derived extracellular vesicles from patients with Parkinson’s disease induce symptoms and pathology Shay Herman, Ruth Djaldetti, Brit Mollenhauer, Daniel Offen Brain.2023; 146(1): 209. CrossRef
Overexpression-Induced α-Synuclein Brain Spreading Rita Pinto-Costa, Eugenia Harbachova, Pietro La Vitola, Donato A. Di Monte Neurotherapeutics.2023; 20(1): 83. CrossRef
The Role of α-Synuclein in the Regulation of Serotonin System: Physiological and Pathological Features Lluis Miquel-Rio, Unai Sarriés-Serrano, Rubén Pavia-Collado, J Javier Meana, Analia Bortolozzi Biomedicines.2023; 11(2): 541. CrossRef
Duodenal alpha‐Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease Aron Emmi, Michele Sandre, Francesco Paolo Russo, Giulia Tombesi, Federica Garrì, Marta Campagnolo, Miryam Carecchio, Roberta Biundo, Gaya Spolverato, Veronica Macchi, Edoardo Savarino, Fabio Farinati, Piero Parchi, Andrea Porzionato, Luigi Bubacco, Raffa Movement Disorders.2023; 38(5): 885. CrossRef
Retina-to-brain spreading of α-synuclein after intravitreal injection of preformed fibrils Dayana Pérez-Acuña, Ka Hyun Rhee, Soo Jean Shin, Jeeyun Ahn, Jee-Young Lee, Seung-Jae Lee Acta Neuropathologica Communications.2023;[Epub] CrossRef
Apathy in Parkinson’s Disease: Clinical Patterns and Neurobiological Basis Matthieu Béreau, Vincent Van Waes, Mathieu Servant, Eloi Magnin, Laurent Tatu, Mathieu Anheim Cells.2023; 12(12): 1599. CrossRef
Translating Pathological Brain Activity Primers in Parkinson’s Disease Research Daniela Mirzac, Svenja L. Kreis, Heiko J. Luhmann, Gabriel Gonzalez-Escamilla, Sergiu Groppa Research.2023;[Epub] CrossRef
Animal models of Parkinson’s disease: bridging the gap between disease hallmarks and research questions Axelle Dovonou, Cyril Bolduc, Victoria Soto Linan, Charles Gora, Modesto R. Peralta III, Martin Lévesque Translational Neurodegeneration.2023;[Epub] CrossRef
The Poly-Arginine Peptide R18D Interferes with the Internalisation of α-Synuclein Pre-Formed Fibrils in STC-1 Enteroendocrine Cells Anastazja M. Gorecki, Holly Spencer, Bruno P. Meloni, Ryan S. Anderton Biomedicines.2023; 11(8): 2089. CrossRef
Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain Shuyu Zhang, Karina Dauer, Timo Strohäker, Lars Tatenhorst, Lucas Caldi Gomes, Simon Mayer, Byung Chul Jung, Woojin S. Kim, Seung‐Jae Lee, Stefan Becker, Friederike Liesche‐Starnecker, Markus Zweckstetter, Paul Lingor Brain Pathology.2023;[Epub] CrossRef
Aging, Parkinson’s Disease, and Models: What Are the Challenges? Emily Rocha, Manish Chamoli, Shankar J. Chinta, Julie K. Andersen, Ruby Wallis, Erwan Bezard, Matt Goldberg, Tim Greenamyre, Warren Hirst, We-Li Kuan, Deniz Kirik, Laura Niedernhofer, Irit Rappley, Shalini Padmanabhan, Louis-Eric Trudeau, Maria Spillantin Aging Biology.2023; 1(1): 20230010. CrossRef
A Novel NOX Inhibitor Alleviates Parkinson’s Disease Pathology in PFF-Injected Mice Kwadwo Ofori, Anurupa Ghosh, Dinesh Kumar Verma, Darice Wheeler, Gabriela Cabrera, Jong-Bok Seo, Yong-Hwan Kim International Journal of Molecular Sciences.2023; 24(18): 14278. CrossRef
Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain Margaux Teil, Sandra Dovero, Mathieu Bourdenx, Marie-Laure Arotcarena, Morgane Darricau, Gregory Porras, Marie-Laure Thiolat, Inés Trigo-Damas, Celine Perier, Cristina Estrada, Nuria Garcia-Carrillo, María Trinidad Herrero, Miquel Vila, José A. Obeso, Erw npj Parkinson's Disease.2023;[Epub] CrossRef
Immunization Effects of a Novel α-Synuclein-Based Peptide Epitope Vaccine in Parkinson’s Disease-Associated Pathology Jun Sung Park, Riaz Ahmad, Kyonghwan Choe, Min Hwa Kang, Tae Ju Park, Myeong Ok Kim Vaccines.2023; 11(12): 1820. CrossRef
Ellagic Acid Prevents α-Synuclein Spread and Mitigates Toxicity by Enhancing Autophagic Flux in an Animal Model of Parkinson’s Disease Nada Radwan, Engila Khan, Mustafa T. Ardah, Tohru Kitada, M. Emdadul Haque Nutrients.2023; 16(1): 85. CrossRef
DA-9805 protects dopaminergic neurons from endoplasmic reticulum stress and inflammation Sora Kang, Ying Piao, Young Cheol Kang, Suyeol Lim, Youngmi Kim Pak Biomedicine & Pharmacotherapy.2022; 145: 112389. CrossRef
Endogenous Levels of Alpha-Synuclein Modulate Seeding and Aggregation in Cultured Cells Eftychia Vasili, Antonio Dominguez-Meijide, Manuel Flores-León, Mohammed Al-Azzani, Angeliki Kanellidi, Ronald Melki, Leonidas Stefanis, Tiago Fleming Outeiro Molecular Neurobiology.2022; 59(2): 1273. CrossRef
Phosphorylation of endogenous α-synuclein induced by extracellular seeds initiates at the pre-synaptic region and spreads to the cell body Shiori Awa, Genjiro Suzuki, Masami Masuda-Suzukake, Takashi Nonaka, Minoru Saito, Masato Hasegawa Scientific Reports.2022;[Epub] CrossRef
Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy Thuy Thi Lai, Yun Joong Kim, Hyeo-il Ma, Young Eun Kim Journal of Movement Disorders.2022; 15(1): 1. CrossRef
α-Synuclein in Parkinson's disease and advances in detection Rong Chen, Xuan Gu, Xiaoying Wang Clinica Chimica Acta.2022; 529: 76. CrossRef
Neurons with Cat’s Eyes: A Synthetic Strain of α-Synuclein Fibrils Seeding Neuronal Intranuclear Inclusions Francesca De Giorgi, Muhammed Bilal Abdul-Shukkoor, Marianna Kashyrina, Leslie-Ann Largitte, Francesco De Nuccio, Brice Kauffmann, Alons Lends, Florent Laferrière, Sébastien Bonhommeau, Dario Domenico Lofrumento, Luc Bousset, Erwan Bezard, Thierry Buffete Biomolecules.2022; 12(3): 436. CrossRef
A Novel NOX Inhibitor Treatment Attenuates Parkinson’s Disease-Related Pathology in Mouse Models Anurupa A. Ghosh, Dinesh Kumar Verma, Gabriela Cabrera, Kwadwo Ofori, Karina Hernandez-Quijada, Jae-Kwan Kim, Joo Hee Chung, Michael Moore, Sung Hwan Moon, Jong Bok Seo, Yong-Hwan Kim International Journal of Molecular Sciences.2022; 23(8): 4262. CrossRef
Do Naturally Occurring Antioxidants Protect Against Neurodegeneration
of the Dopaminergic System? A Systematic Revision in Animal Models of
Parkinson's Disease Carmen Costas, Lilian R.F. Faro Current Neuropharmacology.2022; 20(2): 432. CrossRef
NXP031 prevents dopaminergic neuronal loss and oxidative damage in the AAV-WT-α-synuclein mouse model of Parkinson’s disease Min Kyung Song, Levi Adams, Joo Hee Lee, Yoon-Seong Kim, Hemant K. Paudel PLOS ONE.2022; 17(7): e0272085. CrossRef
Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo Rachel E. Lackie, Aline S. de Miranda, Mei Peng Lim, Vladislav Novikov, Nimrod Madrer, Nadun C. Karunatilleke, Benjamin S. Rutledge, Stephanie Tullo, Anne Brickenden, Matthew E. R. Maitland, David Greenberg, Daniel Gallino, Wen Luo, Anoosha Attaran, Irina Acta Neuropathologica.2022; 144(5): 881. CrossRef
Nanomedicine in the Face of Parkinson’s Disease: From Drug Delivery Systems to Nanozymes Francisco J. Padilla-Godínez, Leonardo I. Ruiz-Ortega, Magdalena Guerra-Crespo Cells.2022; 11(21): 3445. CrossRef
Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases: An Overview Andreza Fabro de Bem, Rachel Krolow, Hémelin Resende Farias, Victória Linden de Rezende, Daniel Pens Gelain, José Cláudio Fonseca Moreira, João Miguel das Neves Duarte, Jade de Oliveira Frontiers in Neuroscience.2021;[Epub] CrossRef
Role of Liver Growth Factor (LGF) in Parkinson’s Disease: Molecular Insights and Therapeutic Opportunities Efthalia Angelopoulou, Yam Nath Paudel, Christina Piperi Molecular Neurobiology.2021; 58(7): 3031. CrossRef
Trans-synaptic spreading of alpha-synuclein pathology through sensory afferents leads to sensory nerve degeneration and neuropathic pain Nelson Ferreira, Nádia Pereira Gonçalves, Asad Jan, Nanna Møller Jensen, Amelia van der Laan, Simin Mohseni, Christian Bjerggaard Vægter, Poul Henning Jensen Acta Neuropathologica Communications.2021;[Epub] CrossRef
Pharmacological Inhibition of Brain EGFR Activation By a BBB-penetrating Inhibitor, AZD3759, Attenuates α-synuclein Pathology in a Mouse Model of α-Synuclein Propagation Omid Tavassoly, Esther del Cid Pellitero, Frederique Larroquette, Eddie Cai, Rhalena A. Thomas, Vincent Soubannier, Wen Luo, Thomas M. Durcan, Edward A. Fon Neurotherapeutics.2021; 18(2): 979. CrossRef
The Future of Incretin-Based Approaches for Neurodegenerative Diseases in Older Adults: Which to Choose? A Review of their Potential Efficacy and Suitability Christine Girges, Nirosen Vijiaratnam, Dilan Athauda, Grace Auld, Sonia Gandhi, Thomas Foltynie Drugs & Aging.2021; 38(5): 355. CrossRef
Prodromal neuroinvasion of pathological α-synuclein in brainstem reticular nuclei and white matter lesions in a model of α-synucleinopathy Nelson Ferreira, Mette Richner, Amelia van der Laan, Ida Bergholdt Jul Christiansen, Christian B Vægter, Jens R Nyengaard, Glenda M Halliday, Joachim Weis, Benoit I Giasson, Ian R Mackenzie, Poul H Jensen, Asad Jan Brain Communications.2021;[Epub] CrossRef
Impact of the apelin/APJ axis in the pathogenesis of Parkinson’s disease with therapeutic potential Efthalia Angelopoulou, Yam Nath Paudel, Anastasia Bougea, Christina Piperi Journal of Neuroscience Research.2021; 99(9): 2117. CrossRef
Adenovirus-induced Reactive Astrogliosis Exacerbates the Pathology of Parkinson’s Disease Heeyoung An, Hyowon Lee, Seulkee Yang, Woojin Won, C. Justin Lee, Min-Ho Nam Experimental Neurobiology.2021; 30(3): 222. CrossRef
Brain iron enrichment attenuates α‐synuclein spreading after injection of preformed fibrils Karina Dauer née Joppe, Lars Tatenhorst, Lucas Caldi Gomes, Shuyu Zhang, Mojan Parvaz, Eleonora Carboni, Anna‐Elisa Roser, Hazem El DeBakey, Mathias Bähr, Katarina Vogel‐Mikuš, Chi Wang Ip, Stefan Becker, Markus Zweckstetter, Paul Lingor Journal of Neurochemistry.2021; 159(3): 554. CrossRef
Increased oscillatory power in a computational model of the olfactory bulb due to synaptic degeneration J. Kendall Berry, Daniel Cox Physical Review E.2021;[Epub] CrossRef
Combining Automated Organoid Workflows with Artificial Intelligence‐Based Analyses: Opportunities to Build a New Generation of Interdisciplinary High‐Throughput Screens for Parkinson's Disease and Beyond Henrik Renner, Hans R. Schöler, Jan M. Bruder Movement Disorders.2021; 36(12): 2745. CrossRef
Is Multiple System Atrophy a Prion-like Disorder? Kurt A. Jellinger, Gregor K. Wenning, Nadia Stefanova International Journal of Molecular Sciences.2021; 22(18): 10093. CrossRef
Cortical alpha-synuclein preformed fibrils do not affect interval timing in mice Qiang Zhang, Hisham Abdelmotilib, Travis Larson, Cameron Keomanivong, Mackenzie Conlon, Georgina M. Aldridge, Nandakumar S. Narayanan Neuroscience Letters.2021; 765: 136273. CrossRef
Temporal Evolution of Inflammation and Neurodegeneration With Alpha-Synuclein Propagation in Parkinson's Disease Mouse Model Thuy Thi Lai, Yun Joong Kim, Phuong Thi Nguyen, Young Ho Koh, Tinh Thi Nguyen, Hyeo-il Ma, Young Eun Kim Frontiers in Integrative Neuroscience.2021;[Epub] CrossRef
The Concept of α-Synuclein Strains and How Different Conformations May Explain Distinct Neurodegenerative Disorders Katja Malfertheiner, Nadia Stefanova, Antonio Heras-Garvin Frontiers in Neurology.2021;[Epub] CrossRef
A historical review of multiple system atrophy with a critical appraisal of cellular and animal models David J. Marmion, Wouter Peelaerts, Jeffrey H. Kordower Journal of Neural Transmission.2021; 128(10): 1507. CrossRef
Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines Masaru Tanaka, József Toldi, László Vécsei International Journal of Molecular Sciences.2020; 21(7): 2431. CrossRef
Modeling Parkinson’s Disease With the Alpha-Synuclein Protein Mónica Gómez-Benito, Noelia Granado, Patricia García-Sanz, Anne Michel, Mireille Dumoulin, Rosario Moratalla Frontiers in Pharmacology.2020;[Epub] CrossRef
Enhanced Susceptibility of PINK1 Knockout Rats to α-Synuclein Fibrils Rose B. Creed, Matthew S. Goldberg Neuroscience.2020; 437: 64. CrossRef
Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein Yuan Guan, Xiaofang Zhao, Fengwei Liu, Shuxin Yan, Yalong Wang, Cuilian Du, Xiuyu Cui, Rena Li, Claire Xi Zhang Frontiers in Cellular Neuroscience.2020;[Epub] CrossRef
Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes Alessia Indrieri, Rocco Pizzarelli, Brunella Franco, Elvira De Leonibus Frontiers in Neuroscience.2020;[Epub] CrossRef
Classic and evolving animal models in Parkinson's disease Tanvi Pingale, Girdhari Lal Gupta Pharmacology Biochemistry and Behavior.2020; 199: 173060. CrossRef